131I-apamistamab
AIM-300
Phase 3 small_molecule active
Quick answer
131I-apamistamab for Acute Leukemia is a Phase 3 program (small_molecule) at Actinium Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Actinium Pharmaceuticals
- Indication
- Acute Leukemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active